Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 465 - 472 of 11616 results

Drugmakers Exposed to Antitrust Probes if Patent Cache Added

May 1, 2024| News

Raising a Venture Fund Now Often Takes Two Years—or Longer

May 1, 2024| News

LPs Warm Back Up To Crypto As Bitcoin Rallies

May 1, 2024| News

The Impact Of New Fiduciary Rule On 401k Plan Sponsors

April 30, 2024| News

PhRMA to Revive Medicare Drug Price Lawsuit Before Fifth Circuit

April 30, 2024| News

What The New Fiduciary Rule Means For Your Retirement Savings

April 30, 2024| News

LDT Oversight Gets Long-Awaited FDA Final Rule

April 30, 2024| News

Industry Fears CERCLA PFAS Rule Will Drive Expanded Five-Year Reviews

April 30, 2024| News

News & Press Releases

Mintz Announces New Members

December 20, 2024

Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.

Mintz Advises US Department of Energy LPO on $1.45B Loan Guarantee to Qcells

December 20, 2024

Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.

Dealmaking Dormant No More

December 17, 2024

International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.

View all News and Press Releases